27 results match your criteria: "Kennedy Institute of Rheumatology and.[Affiliation]"
J Immunol
June 1997
Kennedy Institute of Rheumatology and The Anthony Nolan Bone Marrow Trust and the Department of Hematology, The Royal Free Hospital, London, United Kingdom.
We confirm that IL-10 is produced comparatively late after the activation of human T cells via CD3 stimulation, after IL-2 and IFN-gamma. Furthermore we show that IL-10 production by human T cell lines, such as IFN-gamma and IL-2, is inhibited by the immunosuppressive drugs cyclosporin A and FK506. However, a third immunosuppressive drug, rapamycin, normally associated with inhibiting the effects, but not the production, of cytokines, inhibited IL-10, but not IFN-gamma, production.
View Article and Find Full Text PDF